<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Adverse effects of supplemental oxygen
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Adverse effects of supplemental oxygen
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Adverse effects of supplemental oxygen
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Atul Malhotra, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Richard M Schwartzstein, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Scott Manaker, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Geraldine Finlay, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Apr 08, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Supplemental oxygen is valuable and lifesaving in many clinical situations. However, excessive amounts or inappropriate use of supplemental oxygen can have adverse effects [
         <a href="#rid1">
          1-3
         </a>
         ].
        </p>
        <p>
         The adverse effects of supplemental oxygen are reviewed here. Specific issues including the indications and prescription of long-term oxygen, ideal oxygen targets, and adverse effects of hyperbaric oxygen are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1445.html" rel="external">
          "Long-term supplemental oxygen therapy"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1640.html" rel="external">
          "Overview of initiating invasive mechanical ventilation in adults in the intensive care unit", section on 'Fraction of inspired oxygen'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/326.html" rel="external">
          "Hyperbaric oxygen therapy", section on 'Complications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3529815254">
         <span class="h1">
          TERMINOLOGY
         </span>
        </p>
        <p class="headingAnchor" id="H1484128364">
         <span class="h2">
          Oxygen toxicity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oxygen toxicity is considered to be a harmful effect of inspired oxygen at pressures greater than atmospheric pressure (ie, &gt;0.21 inspired fraction of oxygen at sea level). Oxygen toxicity can be caused by hyperoxia and hyperoxemia and is generally responsible for parenchymal lung injury. (See
         <a class="local">
          'Lung parenchymal injury'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1329561726">
         <span class="h2">
          Hyperoxia and hyperoxemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hyperoxia may be loosely defined as an excess of oxygen in tissue (ie, "more oxygen than is needed"). However, there is no specific oxygen tension included in the definition. The degree of hyperoxia that is harmful is poorly defined, and it is likely different in healthy compared with unhealthy individuals. Unnecessary high fraction of inspired oxygen (FiO
         <sub>
          2
         </sub>
         ) is a common cause of hyperoxia.
        </p>
        <p>
         Hyperoxemia refers to an excess of oxygen in the blood. It is reflected by the arterial oxygen tension (PaO
         <sub>
          2
         </sub>
         ) and most often due to high FiO
         <sub>
          2
         </sub>
         .
        </p>
        <p>
         Notably, in the lung, cellular exposure to oxygen comes directly from the effect of inspired gas on lung tissue (hyperoxia) as well as the amount of oxygen in the blood (hyperoxemia). By contrast, for the rest of the body, cellular exposure to oxygen is only determined by the amount of oxygen in the blood; in this situation hyperoxia is the same as hyperoxemia.
        </p>
        <p class="headingAnchor" id="H1403651196">
         <span class="h1">
          MECHANISM OF ADVERSE EFFECTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, the mechanisms that underlie the deleterious effects of supplemental oxygen are poorly understood. Several mechanisms have been described including the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Direct toxicity – The direct toxic effect of oxygen itself at a cellular level (oxygen toxicity) can cause, for example, lung parenchymal or retinal injury. (See
         <a class="local">
          'Lung parenchymal injury'
         </a>
         below and
         <a class="local">
          'Retinopathy of prematurity'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Physiologic effects – Physiologic effects of supplemental oxygen can alter gas exchange resulting in oxygen-induced hypercapnia or alterations in vascular tone. (See
         <a class="local">
          'Accentuation of hypercapnia'
         </a>
         below and
         <a class="local">
          'Cardiovascular effects'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Local effects – Local adverse effects of oxygen include burns or hypoxia from equipment failure. (See
         <a class="local">
          'Local'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Multifactorial – Several mechanisms may play a role together in producing the adverse effects of oxygen (eg, atelectasis and airway injury). (See
         <a class="local">
          'Other pulmonary adverse effects'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3650694855">
         <span class="h1">
          LUNG PARENCHYMAL INJURY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Adverse effects of oxygen on the lung parenchyma may result from hyperoxia at the alveolus, blood, or cellular level. The strongest level of evidence supports direct cellular injury from reactive oxygen species due to hyperoxia. Importantly, when indicated, oxygen should not be withheld on the basis of preventing oxygen toxicity.
        </p>
        <p>
         Hyperoxia appears to produce cellular injury through increased production of reactive oxygen intermediates (ROIs), such as the superoxide anion, the hydroxyl radical, and hydrogen peroxide [
         <a href="#rid4">
          4,5
         </a>
         ]. When the production of ROIs increases and/or the cell's antioxidant defenses are depleted, they can react with and impair the function of essential intracellular molecules, resulting in cell damage and/or death [
         <a href="#rid6">
          6
         </a>
         ]. ROIs may also promote a deleterious inflammatory response, leading to secondary tissue damage and/or apoptosis [
         <a href="#rid7">
          7-9
         </a>
         ].
        </p>
        <p>
         Much of the evidence supporting direct cellular injury due to ROIs comes from studies in transgenic mice with altered superoxide dismutase activity. Mice with augmented antioxidant mechanisms are relatively tolerant to hyperoxia, while manganese superoxide dismutase knockout mice die shortly after birth with extensive mitochondrial injury within degenerating neurons and cardiac myocytes [
         <a href="#rid10">
          10-12
         </a>
         ]. Data from animal models suggest possible roles for insulin growth factor 1 [
         <a href="#rid13">
          13
         </a>
         ] and angiopoietin 2 [
         <a href="#rid14">
          14
         </a>
         ] in the pathogenesis of hyperoxia-induced lung injury.
        </p>
        <p>
         Evidence from humans is limited and largely derived from healthy individuals [
         <a href="#rid15">
          15
         </a>
         ]. Determining the magnitude of parenchymal injury due solely to oxygen therapy in humans is problematic because confounders are always present (eg, the presence of diseased lung, comorbidities). In addition, since many lung diseases are heterogeneous, the impact of oxygen on non-diseased regions compared with diseased regions is unclear.
        </p>
        <p class="headingAnchor" id="H4084474900">
         <span class="h2">
          At-risk patients
         </span>
         <span class="headingEndMark">
          —
         </span>
         Any patient receiving supplemental oxygen is potentially exposed to the direct toxic of oxygen. However, parameters above which exposure results in clinically meaningful adverse effects are uncertain and vary from patient to patient. In general, we consider patients who are at greatest risk of oxygen toxicity as those who are receiving mechanical ventilation for respiratory failure with a fraction of inspired oxygen (FiO
         <sub>
          2
         </sub>
         ) greater than 0.6 for prolonged durations (eg, &gt;24 hours) [
         <a href="#rid16">
          16-18
         </a>
         ].
        </p>
        <p>
         Factors that can modulate the impact of supplemental oxygen to alter the level at which toxicity can occur are discussed in the sections below:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="local">
          'High fraction of inspired oxygen for prolonged periods'
         </a>
         below.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="local">
          'Select drugs or radiation'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p>
         Whether underlying lung disease, other than drug- or radiation-induced lung injury or ischemia during cardiac arrest, contributes to oxygen toxicity is unknown. (See
         <a class="local">
          'Underlying lung disease'
         </a>
         below and
         <a class="local">
          'Post-cardiac arrest'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1127198043">
         <span class="h3">
          High fraction of inspired oxygen for prolonged periods
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, the risk of oxygen toxicity correlates with the FiO
         <sub>
          2
         </sub>
         and the duration of exposure (ie, the higher the FiO
         <sub>
          2
         </sub>
         and longer the duration, the higher the risk).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         FiO
         <sub>
          2
         </sub>
         – Although there is no cutoff level above which toxicity can occur, in patients who are mechanically ventilated for acute respiratory distress syndrome (ARDS), we generally consider an FiO
         <sub>
          2
         </sub>
         &gt;0.6 as a level that places patients at risk for oxygen-induced lung damage.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Duration – At an FiO
         <sub>
          2
         </sub>
         of 1.0, evidence of cellular toxicity can be seen as early as 24 hours in healthy lungs [
         <a href="#rid16">
          16-18
         </a>
         ]. However, the amount of time required to see pathologic changes in the lung is inversely related to the FiO
         <sub>
          2
         </sub>
         . For example, the time interval to injury increases as FiO
         <sub>
          2
         </sub>
         is reduced while the time interval decreases as the FiO
         <sub>
          2
         </sub>
         is increased.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3270796836">
         <span class="h3">
          Select drugs or radiation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some drugs (most notably
         <a class="drug drug_general" data-topicid="9160" href="/z/d/drug information/9160.html" rel="external">
          bleomycin
         </a>
         and
         <a class="drug drug_general" data-topicid="8595" href="/z/d/drug information/8595.html" rel="external">
          amiodarone
         </a>
         ) and radiation exposure appear to sensitize the lung to oxygen such that toxicity may occur at a lower FiO
         <sub>
          2
         </sub>
         than in healthy lungs.
        </p>
        <p>
         Patients who receive
         <a class="drug drug_general" data-topicid="9160" href="/z/d/drug information/9160.html" rel="external">
          bleomycin
         </a>
         appear to be more susceptible to the development of diffuse alveolar damage (ie, the pathology associated with acute respiratory distress syndrome) following oxygen exposure, based upon in vitro data and clinical experience [
         <a href="#rid19">
          19-22
         </a>
         ]. The typical presentation involves a patient who, after receiving bleomycin, requires high FiO
         <sub>
          2
         </sub>
         in the subsequent weeks to months (eg, due to aspiration, pneumonia, or general anesthesia). The patient develops acute, subacute, or chronic worsening of bilateral alveolar infiltrates with increasing dyspnea, nonproductive cough, and decreasing lung compliance. However, such presentations can occur years to decades after the initial bleomycin exposure for unclear reasons. (See
         <a class="medical medical_review" href="/z/d/html/4316.html" rel="external">
          "Bleomycin-induced lung injury"
         </a>
         .)
        </p>
        <p>
         Oxygen-induced lung injury associated with
         <a class="drug drug_general" data-topicid="8595" href="/z/d/drug information/8595.html" rel="external">
          amiodarone
         </a>
         or external beam radiation may have a similar pathogenesis and presentation to that of
         <a class="drug drug_general" data-topicid="9160" href="/z/d/drug information/9160.html" rel="external">
          bleomycin
         </a>
         when patients are exposed to hyperoxic conditions. (See
         <a class="medical medical_review" href="/z/d/html/4364.html" rel="external">
          "Amiodarone pulmonary toxicity"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4331.html" rel="external">
          "Radiation-induced lung injury"
         </a>
         .)
        </p>
        <p>
         The potential for oxygen toxicity must be communicated to the anesthesiologist if a patient with
         <a class="drug drug_general" data-topicid="9160" href="/z/d/drug information/9160.html" rel="external">
          bleomycin
         </a>
         ,
         <a class="drug drug_general" data-topicid="8595" href="/z/d/drug information/8595.html" rel="external">
          amiodarone
         </a>
         , or radiation exposure needs a surgical or endoscopic procedure.
        </p>
        <p class="headingAnchor" id="H674151238">
         <span class="h3">
          Underlying lung disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is unknown whether underlying lung disease other than that induced by drugs or radiation predisposes the lung to the direct toxic effects of oxygen.
        </p>
        <p>
         Chronic low levels of exposure, such as that administered in patients on lower levels of oxygen at home may result in cellular changes in the lung but is of uncertain significance and should not preclude its administration, when indicated. (See
         <a class="local">
          'Adults on long-term oxygen'
         </a>
         below.)
        </p>
        <p>
         Although not a direct toxic effect, oxygen-induced hypercapnia may also occur in patients with chronic lung disease. (See
         <a class="local">
          'Accentuation of hypercapnia'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4076830523">
         <span class="h3">
          Post-cardiac arrest
         </span>
         <span class="headingEndMark">
          —
         </span>
         Uncontrolled studies suggest that hyperoxemia may worsen outcomes in patients who survive cardiac arrest [
         <a href="#rid23">
          23
         </a>
         ]. However, it is not clear whether adverse outcomes are due to the direct toxic effect of oxygen or to other factors such as lung ischemia, low minute ventilation, or reperfusion injury.
        </p>
        <p class="headingAnchor" id="H1583033791">
         <span class="h2">
          Physiologic, clinical, pathologic impact
         </span>
         <span class="headingEndMark">
          —
         </span>
         Outcomes associated with the adverse of oxygen are poorly studied but include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Physiologic – Older studies in humans reported conflicting evidence of the effect of hyperoxia on physiologic parameters such as increased right-to-left shunt fraction, reduced lung compliance, increased dead space to tidal volume ratio, and reduced diffusing capacity [
         <a href="#rid24">
          24-26
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Clinical – Newer studies have focused on examining the impact of liberal versus conservative oxygenation strategies on survival, length of stay, and ventilator-free days. These studies have examined the effect of hyperoxemia, however, not hyperoxia per se. In general, data cumulatively support use of conservative strategies. These data are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1640.html" rel="external">
          "Overview of initiating invasive mechanical ventilation in adults in the intensive care unit", section on 'Fraction of inspired oxygen'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pathologic – The pathologic outcome of oxygen toxicity is unclear but may range from mild inflammation to diffuse alveolar damage, similar to that seen in ARDS. (See
         <a class="medical medical_review" href="/z/d/html/1637.html" rel="external">
          "Acute respiratory distress syndrome: Clinical features, diagnosis, and complications in adults", section on 'Pathologic diagnosis and stages'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16921.html" rel="external">
          "Interpretation of lung biopsy results in interstitial lung disease", section on 'Diffuse alveolar damage'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2102522502">
         <span class="h2">
          Prevention
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is no single threshold of FiO
         <sub>
          2
         </sub>
         that defines a safe upper limit to prevent oxygen toxicity. As a general principle, we reduce the FiO
         <sub>
          2
         </sub>
         to the lowest achievable fraction in order to obtain a target arterial oxygen tension (PaO
         <sub>
          2
         </sub>
         ) or peripheral oxygen saturation (SpO
         <sub>
          2
         </sub>
         ) and avoid hyperoxia, when feasible. However, since oxygenation targets vary depending on the population being treated, we individualize oxygenation goals. Reasonable targets are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/1640.html" rel="external">
          "Overview of initiating invasive mechanical ventilation in adults in the intensive care unit", section on 'Fraction of inspired oxygen'
         </a>
         .)
        </p>
        <p>
         Preventative strategies are most important in those at risk. In patients who are mechanically ventilated for ARDS, we target an FiO
         <sub>
          2
         </sub>
         &lt;0.6 based upon the rationale that such a target is unlikely to induce clinically significant oxygen toxicity, unless sensitizing agents are administered (see
         <a class="local">
          'At-risk patients'
         </a>
         above). A number of therapeutic strategies can be employed in this population to minimize the need for a high FiO
         <sub>
          2
         </sub>
         &gt;0.6 and thereby reduce the risk of oxygen toxicity (eg, positive end expiratory pressure, prone positioning). In our practice, we begin to implement these measures as soon as it is evident that the patient will require FiO
         <sub>
          2
         </sub>
         &gt;0.6 for longer than six hours. These strategies are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1653.html" rel="external">
          "Acute respiratory distress syndrome: Ventilator management strategies for adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          OTHER PULMONARY ADVERSE EFFECTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         In adults, oxygen, particularly high fractions of inspired oxygen (eg, FiO
         <sub>
          2
         </sub>
         &gt; 0.6) have been associated with several effects on lung tissue and gas exchange including diminished lung volumes and hypoxemia due to absorptive atelectasis, damage to airways, and accentuation or production of hypercapnia. (See
         <a class="local">
          'Absorptive atelectasis'
         </a>
         below and
         <a class="local">
          'Airway injury'
         </a>
         below and
         <a class="local">
          'Accentuation of hypercapnia'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Absorptive atelectasis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Absorptive atelectasis is a process where high FiO
         <sub>
          2
         </sub>
         results in washout of alveolar nitrogen (ie, nitrogen is replaced by oxygen). The oxygen is rapidly absorbed into the blood, resulting in a reduction in the size of the alveolus and alveolar closure (ie, atelectasis).
        </p>
        <p>
         Patients at particular risk of absorptive atelectasis include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with a low regional ventilation-perfusion ratio (ie, oxygen diffuses from alveoli to capillaries faster than it is replenished by inhaled oxygen). Patients with regional areas of hypoventilation, such as chronic obstructive pulmonary disease (COPD) or an occluded airway from a foreign body or neoplasm, are particularly at risk.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with qualitative or quantitative surfactant abnormalities that promote alveolar collapse and further reduce the ventilation-perfusion ratio (eg, patients with acute respiratory distress syndrome).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with a high rate of oxygen uptake, due to an increase in metabolic demand (eg, fever, hyperthyroidism).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with an impaired pattern of respiration that fails to correct atelectasis (eg, ventilation at low tidal volumes and/or without intermittent sighs or "adequate" positive end expiratory pressure [PEEP]).
        </p>
        <p>
        </p>
        <p>
         The impact of atelectasis includes the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Worsening hypoxemia – Atelectasis contributes to worsening hypoxemia by increasing right-to-left shunt (see
         <a class="medical medical_review" href="/z/d/html/1647.html" rel="external">
          "Measures of oxygenation and mechanisms of hypoxemia", section on 'Right-to-left shunt'
         </a>
         ). Shunting resulting from absorptive atelectasis is generally minor in younger patients with healthy lungs, but can be as high as 11 percent in older healthy volunteers [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Reduced vital capacity – Atelectasis may also contribute to a reduction in vital capacity. Reductions in vital capacity of up to 20 percent have been noted after hyperoxic exposure in a number of studies [
         <a href="#rid28">
          28,29
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Atelectasis may be evidenced by inspiratory crackles or rales on physical examination and worsening oxygenation and can be confirmed by chest radiographs and/or computed tomography scan of the chest.
        </p>
        <p>
         Once established, absorptive atelectasis is not directly reversed by a reduction of FiO
         <sub>
          2
         </sub>
         , emphasizing the importance of rapid titration of FiO
         <sub>
          2
         </sub>
         to the lowest fraction necessary to maintain the desired target arterial oxygen saturation [
         <a href="#rid30">
          30
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1640.html" rel="external">
          "Overview of initiating invasive mechanical ventilation in adults in the intensive care unit", section on 'Fraction of inspired oxygen'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Airway injury
         </span>
         <span class="headingEndMark">
          —
         </span>
         Supplemental oxygen has been implicated in the development of airway injury in response to hyperoxia.
        </p>
        <p>
         Many healthy volunteers experience substernal heaviness, pleuritic chest pain, cough, and dyspnea within 24 hours of breathing 100 percent oxygen. These symptoms are probably due to a combination of tracheobronchitis and absorptive atelectasis [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
         Erythema and edema of large airways can be observed bronchoscopically in most patients treated with a FiO
         <sub>
          2
         </sub>
         of 0.9 for six hours and are thought to reflect hyperoxic bronchitis [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
         In addition, the concentration of reactive oxygen intermediates (ROIs) in exhaled gas increases after only one hour of breathing 28 percent oxygen, regardless of the presence of underlying lung disease [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p>
         Airway injury may present with wheeze and increased airway pressures.
        </p>
        <p>
         It is unknown whether reducing FiO
         <sub>
          2
         </sub>
         reverses oxygen toxicity in the airway.
        </p>
        <p class="headingAnchor" id="H3692393353">
         <span class="h2">
          Accentuation of hypercapnia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oxygen-induced hypercapnia describes the phenomenon of increased arterial carbon dioxide tension (PaCO
         <sub>
          2
         </sub>
         ) associated with the administration of supplemental oxygen. In general, increased hypercapnia does not lead to CO
         <sub>
          2
         </sub>
         narcosis and respiratory failure since the relative rise in PaCO
         <sub>
          2
         </sub>
         is small.
        </p>
        <p>
         Oxygen-indued hypercapnia is predominantly described as a complication of supplemental oxygen in individuals with chronic compensated respiratory acidosis (eg, COPD) who are experiencing an exacerbation of their underlying disease.
        </p>
        <p>
         The mechanism and management of oxygen-induced hypercapnia are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1458.html" rel="external">
          "The evaluation, diagnosis, and treatment of the adult patient with acute hypercapnic respiratory failure"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/101436.html" rel="external">
          "Mechanisms, causes, and effects of hypercapnia", section on 'Oxygen-induced hypercapnia'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1458.html" rel="external">
          "The evaluation, diagnosis, and treatment of the adult patient with acute hypercapnic respiratory failure", section on 'Titration of oxygen'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1414051396">
         <span class="h2">
          Other
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hyperoxia may also increase susceptibility to secondary infection by impairing both mucociliary clearance and the bactericidal capacity of immune cells [
         <a href="#rid29">
          29,34-38
         </a>
         ]. However, an actual causative link between oxygen administration and infection is unclear.
        </p>
        <p class="headingAnchor" id="H3763163094">
         <span class="h1">
          EXTRAPULMONARY ADVERSE EFFECTS
         </span>
        </p>
        <p class="headingAnchor" id="H2994507990">
         <span class="h2">
          Local
         </span>
         <span class="headingEndMark">
          —
         </span>
         Local effects of oxygen include nasal dryness (when administered via nasal cannula) and risk of burns and airway fire. These complications can occur in both outpatients who are receiving long-term oxygen therapy (see
         <a class="local">
          'Adults on long-term oxygen'
         </a>
         below) and inpatients receiving supplemental oxygen.
        </p>
        <p>
         For inpatients receiving oxygen, procedures that carry a risk of airway fire (eg, electrocautery, argon laser) are generally avoided but, if oxygen is necessary for a life-saving procedure, the oxygen concentration is lowered and oxygen source kept at a distance from the heat source. Further details are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/4396.html" rel="external">
          "Endobronchial electrocautery", section on 'Complications'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4392.html" rel="external">
          "Bronchoscopic laser in the management of airway disease in adults", section on 'Complications'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4405.html" rel="external">
          "Bronchoscopic argon plasma coagulation in the management of airway disease in adults", section on 'Complications'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94592.html" rel="external">
          "Fire safety in the operating room"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1532768224">
         <span class="h2">
          Cardiovascular effects
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hyperoxemia may also alter cardiovascular function [
         <a href="#rid39">
          39,40
         </a>
         ]. Increased oxygen tension can lead to local coronary vasoconstriction, and microscopic foci of myocardial necrosis have been observed in animal models [
         <a href="#rid41">
          41
         </a>
         ]. Reductions in stroke volume and cardiac output, relative bradycardia, and an increase in systemic vascular resistance may ensue [
         <a href="#rid42">
          42
         </a>
         ]. However, the clinical relevance of hyperoxia-related hemodynamic effects remains unclear. Data in humans are limited but may suggest that hyperoxemia reduces myocardial function and cardiac output and increases systemic vascular resistance [
         <a href="#rid43">
          43-45
         </a>
         ]. Among patients with cardiac disorders, those with heart failure patients may be the most sensitive to the effects of hyperoxemia [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1978254218">
         <span class="h2">
          Central nervous system
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hyperoxemia may increase the risk of central nervous system symptoms including generalized tonic-clonic seizures [
         <a href="#rid46">
          46
         </a>
         ], although seizures are unusual in the absence of hyperbaric therapy. These and other complications of hyperbaric oxygen including barotrauma of the ear, sinuses, and lung, reversible myopia, and lung parenchymal injury are described separately. (See
         <a class="medical medical_review" href="/z/d/html/326.html" rel="external">
          "Hyperbaric oxygen therapy", section on 'Complications'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2024274393">
         <span class="h1">
          SPECIAL POPULATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H3320754105">
         <span class="h2">
          Pediatric
         </span>
        </p>
        <p class="headingAnchor" id="H1791081893">
         <span class="h3">
          Retinopathy of prematurity
         </span>
         <span class="headingEndMark">
          —
         </span>
         The retinopathy of prematurity (previously called retrolental fibroplasia) has been partially attributed to the toxic effects of oxygen. Further details are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/6263.html" rel="external">
          "Retinopathy of prematurity (ROP): Risk factors, classification, and screening"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1270819338">
         <span class="h3">
          Bronchopulmonary dysplasia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bronchopulmonary dysplasia (BPD), a disease seen in neonates following recovery from neonatal respiratory distress syndrome, has been attributed to the effects of mechanical ventilation and oxygen toxicity in the immature lung. BPD is characterized by epithelial hyperplasia and squamous metaplasia in the large airways, thickened alveolar walls, and peribronchial and interstitial fibrosis. Infants with BPD generally suffer respiratory distress and require supplemental oxygen for up to six months. Further details regarding BPD are provided separately. (See
         <a class="medical medical_review" href="/z/d/html/4987.html" rel="external">
          "Bronchopulmonary dysplasia (BPD): Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H236136483">
         <span class="h2">
          Adults on long-term oxygen
         </span>
         <span class="headingEndMark">
          —
         </span>
         Adults receiving long-term oxygen therapy (LTOT) may have the following side effects:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nasal issues
         </strong>
         – Nasal dryness, nosebleeds, and skin irritation (from nasal cannulae or a facemask) are not uncommon and can be alleviated by a water-based nasal lubricant, barrier creams/adhesive, or humification.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Burns
         </strong>
         – Facial and upper airway burns are an infrequent hazard of LTOT, but can be severe and potentially life-threatening [
         <a href="#rid47">
          47-50
         </a>
         ]. However, spontaneous combustion may occur following exposure to a spark source or open flame. It is also hypothesized that certain factors contribute to the risk of combustion in the absence of open flames, such as facial hair and use of hair products containing oils or alcohol [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Patients should be reminded not to smoke while using supplemental oxygen [
         <a href="#rid50">
          50
         </a>
         ], to keep oxygen at least six feet (two meters) away from any open flame, and to be cautious about exposure to sources of heat sparks or gas stoves.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The safety of electronic cigarettes (also known as e-cigarettes, personal vaporizers, or electronic nicotine delivery systems) in the setting of LTOT has not been formally evaluated, but the use of a heat source contained within electronic cigarettes adjacent to oxygen is concerning and further study is needed [
         <a href="#rid52">
          52
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/98400.html" rel="external">
          "Vaping and e-cigarettes"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Accidental falls
         </strong>
         – Patients who wear oxygen may suffer from accidental falls when tubing used to administer oxygen is lengthy to accommodate administration throughout the home (or hospital) dwelling. Education regarding safety is paramount in preventing accidental falls. (See
         <a class="medical medical_review" href="/z/d/html/3012.html" rel="external">
          "Falls in older persons: Risk factors and patient evaluation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Equipment failure
         </strong>
         – Hypoxemia may occur due to power outages and equipment failure.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Possible oxygen toxicity
         </strong>
         – Whether LTOT is associated with a clinically significant effect due to oxygen toxicity is unknown; however, the possibility of oxygen toxicity should not preclude the administration of LTOT, when indicated.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         While LTOT is generally delivered at low fractions of inspired oxygen (eg, FiO
         <sub>
          2
         </sub>
         &lt; 0.28), the duration of exposure is prolonged such that toxicity is plausible.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Limited data support a possible effect of oxygen toxicity that is of uncertain clinical significance. Data are mostly reported in patients with chronic obstructive pulmonary disease (COPD). As an example, in an autopsy series, half of patients with COPD receiving LTOT (for about two years prior to death at an estimated FiO
         <sub>
          2
         </sub>
         of 0.22 to 0.27) displayed classic findings of oxygen toxicity (ie, capillary proliferation, interstitial fibrosis, epithelial and hyperplasia) [
         <a href="#rid53">
          53
         </a>
         ]. Oxidative stress from oxygen and cigarette smoke may also play a role in COPD pathogenesis [
         <a href="#rid54">
          54
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In an effort to limit any potential for oxygen toxicity, we adhere to specific oxygen targets in patients with COPD and extrapolate those targets to patients who require LTOT for other chronic lung disorders. Further details on oxygen targets for patients with COPD are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1445.html" rel="external">
          "Long-term supplemental oxygen therapy", section on 'Oxygen flow rate'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1446427431">
         <span class="h1">
          INVESTIGATIONAL APPROACHES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Because oxygen radicals lead to pulmonary toxicity, enhanced defenses against these molecules theoretically should minimize or prevent lung damage [
         <a href="#rid55">
          55
         </a>
         ]. The potential importance of augmented antioxidant mechanisms is illustrated in several animal models [
         <a href="#rid10">
          10,56-63
         </a>
         ]. Data on the efficacy of these potential therapies in humans are lacking.
        </p>
        <p>
         Manipulation of the cytokine milieu in animals may permit modification of the deleterious inflammatory response provoked by hyperoxia (eg, protective effect of the overexpression of interleukin-11) [
         <a href="#rid7">
          7
         </a>
         ], but human data are lacking.
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Introduction and mechanism
         </strong>
         – Oxygen toxicity is a harmful effect of inspired oxygen at pressures greater than atmospheric pressure. Oxygen toxicity can be caused by hyperoxia (an excess of oxygen in tissue) and hyperoxemia (an excess of oxygen in blood). (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Terminology'
         </a>
         above and
         <a class="local">
          'Mechanism of adverse effects'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lung parenchymal injury
         </strong>
         – Oxygen toxicity appears to produce parenchymal lung injury through increased production of reactive oxygen intermediates (ROIs). (See
         <a class="local">
          'Lung parenchymal injury'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In general, we consider patients who are at greatest risk of oxygen-induced parenchymal lung injury are those on mechanical ventilation for respiratory failure receiving a fraction of inspired oxygen (FiO
         <sub>
          2
         </sub>
         ) greater than 0.6 for prolonged durations (eg, &gt;24 hours). (See
         <a class="local">
          'At-risk patients'
         </a>
         above and
         <a class="local">
          'High fraction of inspired oxygen for prolonged periods'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Select drugs (eg,
         <a class="drug drug_general" data-topicid="9160" href="/z/d/drug information/9160.html" rel="external">
          bleomycin
         </a>
         ,
         <a class="drug drug_general" data-topicid="8595" href="/z/d/drug information/8595.html" rel="external">
          amiodarone
         </a>
         ) and radiation may predispose patients to oxygen-induced lung injury at an FiO
         <sub>
          2
         </sub>
         lower than 0.6. (See
         <a class="local">
          'Select drugs or radiation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         End organ effects of hyperoxia on the lung parenchyma range from mild inflammation to diffuse alveolar damage. (See
         <a class="local">
          'Physiologic, clinical, pathologic impact'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         There is no single threshold of FiO
         <sub>
          2
         </sub>
         that defines a safe upper limit that prevents oxygen-induced parenchymal lung injury. As a general principle, we reduce the FiO
         <sub>
          2
         </sub>
         to the lowest achievable fraction in order to obtain a target arterial oxygen tension (PaO
         <sub>
          2
         </sub>
         ) or peripheral oxygen saturation (SpO
         <sub>
          2
         </sub>
         ) and avoid hyperoxia, when feasible. However, since oxygenation targets vary depending on the population being treated, we individualize oxygenation goals. Reasonable targets are discussed in detail separately. (See
         <a class="local">
          'Prevention'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/1640.html" rel="external">
          "Overview of initiating invasive mechanical ventilation in adults in the intensive care unit", section on 'Fraction of inspired oxygen'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other adverse effects
         </strong>
         – Other pulmonary adverse effects of oxygen include absorptive atelectasis, airway injury, and worsening of hypercapnia. Oxygen also places patients at risk of facial burns and airway fire. Hyperoxemia may also have effects on the cardiovascular and central nervous system but the clinical significance of these effects is uncertain. (See
         <a class="local">
          'Other pulmonary adverse effects'
         </a>
         above and
         <a class="local">
          'Extrapulmonary adverse effects'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Special populations
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Oxygen toxicity has been implicated in retinopathy of prematurity and bronchopulmonary dysplasia in infants. (See
         <a class="local">
          'Pediatric'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/6263.html" rel="external">
          "Retinopathy of prematurity (ROP): Risk factors, classification, and screening"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4987.html" rel="external">
          "Bronchopulmonary dysplasia (BPD): Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Adults receiving long-term oxygen therapy (LTOT) may develop adverse effects including nasal dryness and are at risk of facial or upper airway burns, accidental falls from oxygen tubing, and hypoxemia from equipment failure. Toxicity from LTOT is unlikely to be clinically significant. Oxygen targets for patients with chronic obstructive pulmonary disease (COPD)are discussed separately. (See
         <a class="local">
          'Adults on long-term oxygen'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/1445.html" rel="external">
          "Long-term supplemental oxygen therapy", section on 'Oxygen flow rate'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3400079135">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges David R Schwartz, MD, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Girardis M, Busani S, Damiani E, et al. Effect of Conservative vs Conventional Oxygen Therapy on Mortality Among Patients in an Intensive Care Unit: The Oxygen-ICU Randomized Clinical Trial. JAMA 2016; 316:1583.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chu DK, Kim LH, Young PJ, et al. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis. Lancet 2018; 391:1693.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singer M, Young PJ, Laffey JG, et al. Dangers of hyperoxia. Crit Care 2021; 25:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freeman BA, Crapo JD. Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem 1981; 256:10986.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winslow RM. Oxygen: the poison is in the dose. Transfusion 2013; 53:424.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fridovich I. Oxygen toxicity: a radical explanation. J Exp Biol 1998; 201:1203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waxman AB, Einarsson O, Seres T, et al. Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. J Clin Invest 1998; 101:1970.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barazzone C, Horowitz S, Donati YR, et al. Oxygen toxicity in mouse lung: pathways to cell death. Am J Respir Cell Mol Biol 1998; 19:573.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mantell LL, Lee PJ. Signal transduction pathways in hyperoxia-induced lung cell death. Mol Genet Metab 2000; 71:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           White CW, Avraham KB, Shanley PF, Groner Y. Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity. J Clin Invest 1991; 87:2162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lebovitz RM, Zhang H, Vogel H, et al. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci U S A 1996; 93:9782.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Folz RJ, Abushamaa AM, Suliman HB. Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. J Clin Invest 1999; 103:1055.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim TH, Chow YH, Gill SE, Schnapp LM. Effect of insulin-like growth factor blockade on hyperoxia-induced lung injury. Am J Respir Cell Mol Biol 2012; 47:372.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhandari V, Choo-Wing R, Harijith A, et al. Increased hyperoxia-induced lung injury in nitric oxide synthase 2 null mice is mediated via angiopoietin 2. Am J Respir Cell Mol Biol 2012; 46:668.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shykoff BE, Lee RL. Risks from Breathing Elevated Oxygen. Aerosp Med Hum Perform 2019; 90:1041.
          </a>
         </li>
         <li class="breakAll">
          Clark JM, Lambertson CJ. Pulmonary oxygen tolerance and the rate of development of pulmonary oxygen toxicity in man at two atmospheres inspired oxygen tension. In: Underwater Physiology; Proceedings of the third symposium, Lambertson CJ (Ed), Williams and Wilkins, Baltimore 1967. p.439.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chawla A, Lavania AK. OXYGEN TOXICITY. Med J Armed Forces India 2001; 57:131.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wingelaar TT, van Ooij PAM, Brinkman P, van Hulst RA. Pulmonary Oxygen Toxicity in Navy Divers: A Crossover Study Using Exhaled Breath Analysis After a One-Hour Air or Oxygen Dive at Nine Meters of Sea Water. Front Physiol 2019; 10:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berend N. Protective effect of hypoxia on bleomycin lung toxicity in the rat. Am Rev Respir Dis 1984; 130:307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ingrassia TS 3rd, Ryu JH, Trastek VF, Rosenow EC 3rd. Oxygen-exacerbated bleomycin pulmonary toxicity. Mayo Clin Proc 1991; 66:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matalon S, Harper WV, Goldinger JM, et al. Modification of pulmonary oxygen toxicity by bleomycin treatment. J Appl Physiol (1985) 1985; 58:1802.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gilson AJ, Sahn SA. Reactivation of bleomycin lung toxicity following oxygen administration. A second response to corticosteroids. Chest 1985; 88:304.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Young PJ, Bailey M, Bellomo R, et al. Conservative or liberal oxygen therapy in adults after cardiac arrest: An individual-level patient data meta-analysis of randomised controlled trials. Resuscitation 2020; 157:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singer MM, Wright F, Stanley LK, et al. Oxygen toxicity in man. A prospective study in patients after open-heart surgery. N Engl J Med 1970; 283:1473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barber RE, Hamilton WK. Oxygen toxicity in man. A prospective study in patients with irreversible brain damage. N Engl J Med 1970; 283:1478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elliott CG, Rasmusson BY, Crapo RO, et al. Prediction of pulmonary function abnormalities after adult respiratory distress syndrome (ARDS). Am Rev Respir Dis 1987; 135:634.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wagner PD, Laravuso RB, Uhl RR, West JB. Continuous distributions of ventilation-perfusion ratios in normal subjects breathing air and 100 per cent O2. J Clin Invest 1974; 54:54.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jenkinson SG. Oxygen toxicity. New Horiz 1993; 1:504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carvalho CR, de Paula Pinto Schettino G, Maranhão B, Bethlem EP. Hyperoxia and lung disease. Curr Opin Pulm Med 1998; 4:300.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Santos C, Ferrer M, Roca J, et al. Pulmonary gas exchange response to oxygen breathing in acute lung injury. Am J Respir Crit Care Med 2000; 161:26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Comroe JH, Dripps RD, Dumke PR, Deming M. The effect of inhalation of high concentrations of oxygen for 24 hours on normal men at sea level and at a simulated altitude of 18,000. JAMA 1945; 128:710.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sackner MA, Landa J, Hirsch J, Zapata A. Pulmonary effects of oxygen breathing. A 6-hour study in normal men. Ann Intern Med 1975; 82:40.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, et al. Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation. Thorax 2004; 59:1016.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huber GL, Porter SL, Burley SW, et al. The effect of oxygen toxicity on the inactivation of bacteria by the lung. Chest 1972; 61:Suppl:66S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suttorp N, Simon LM. Decreased bactericidal function and impaired respiratory burst in lung macrophages after sustained in vitro hyperoxia. Am Rev Respir Dis 1983; 128:486.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sackner MA, Hirsch JA, Epstein S, Rywlin AM. Effect of oxygen in graded concentrations upon tracheal mucous velocity. A study in anesthetized dogs. Chest 1976; 69:164.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vlessis AA, Bartos D, Muller P, Trunkey DD. Role of reactive O2 in phagocyte-induced hypermetabolism and pulmonary injury. J Appl Physiol (1985) 1995; 78:112.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Griffith DE, Garcia JG, James HL, et al. Hyperoxic exposure in humans. Effects of 50 percent oxygen on alveolar macrophage leukotriene B4 synthesis. Chest 1992; 101:392.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lodato RF. Effects of normobaric hyperoxia on hemodynamics and O2 utilization in conscious dogs. Adv Exp Med Biol 1990; 277:807.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ganz W, Donoso R, Marcus H, Swan HJ. Coronary hemodynamics and myocardial oxygen metabolism during oxygen breathing in patients with and without coronary artery disease. Circulation 1972; 45:763.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Büsing CM, Kreinsen U, Bühler F, Bleyl U. Light and electron microscopic examinations of experimentally produced heart muscle necroses following normobaric hyperoxia. Virchows Arch A Pathol Anat Histol 1975; 366:137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lodato RF. Decreased O2 consumption and cardiac output during normobaric hyperoxia in conscious dogs. J Appl Physiol (1985) 1989; 67:1551.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smit B, Smulders YM, van der Wouden JC, et al. Hemodynamic effects of acute hyperoxia: systematic review and meta-analysis. Crit Care 2018; 22:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guensch DP, Fischer K, Yamaji K, et al. Effect of Hyperoxia on Myocardial Oxygenation and Function in Patients With Stable Multivessel Coronary Artery Disease. J Am Heart Assoc 2020; 9:e014739.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aguilar D, Nambi V. Taking the Air Out of Oxygen Supplementation in Individuals With Diabetes and Acute Coronary Syndromes. Diabetes Care 2019; 42:2019.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manning EP. Central Nervous System Oxygen Toxicity and Hyperbaric Oxygen Seizures. Aerosp Med Hum Perform 2016; 87:477.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Amani H, Lozano DD, Blome-Eberwein S. Brother, have you got a light? Assessing the need for intubation in patients sustaining burn injury secondary to home oxygen therapy. J Burn Care Res 2012; 33:e280.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murabit A, Tredget EE. Review of burn injuries secondary to home oxygen. J Burn Care Res 2012; 33:212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharma G, Meena R, Goodwin JS, et al. Burn injury associated with home oxygen use in patients with chronic obstructive pulmonary disease. Mayo Clin Proc 2015; 90:492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carlos WG, Baker MS, McPherson KA, et al. Smoking-Related Home Oxygen Burn Injuries: Continued Cause for Alarm. Respiration 2016; 91:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson BW, Greenlund AC, Greenlund LJ. Facial hair: a newly identified, modifiable risk factor in home oxygen therapy-related burns. Mayo Clin Proc 2014; 89:1164.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lacasse Y, Légaré M, Maltais F. E-cigarette use in patients receiving home oxygen therapy. Can Respir J 2015; 22:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Petty TL, Stanford RE, Neff TA. Continuous oxygen therapy in chronic airway obstruction. Observations on possible oxygen toxicity and survival. Ann Intern Med 1971; 75:361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kirkham PA, Barnes PJ. Oxidative stress in COPD. Chest 2013; 144:266.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Comhair SA, Erzurum SC. Antioxidant responses to oxidant-mediated lung diseases. Am J Physiol Lung Cell Mol Physiol 2002; 283:L246.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heffner JE, Repine JE. Pulmonary strategies of antioxidant defense. Am Rev Respir Dis 1989; 140:531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kolleck I, Sinha P, Rüstow B. Vitamin E as an antioxidant of the lung: mechanisms of vitamin E delivery to alveolar type II cells. Am J Respir Crit Care Med 2002; 166:S62.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bitterman N, Melamed Y, Ben-Amotz A. Beta-carotene and CNS oxygen toxicity in rats. J Appl Physiol (1985) 1994; 76:1073.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tang G, White JE, Gordon RJ, et al. Polyethylene glycol-conjugated superoxide dismutase protects rats against oxygen toxicity. J Appl Physiol (1985) 1993; 74:1425.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Turrens JF, Crapo JD, Freeman BA. Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase. J Clin Invest 1984; 73:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dennery PA, Spitz DR, Yang G, et al. Oxygen toxicity and iron accumulation in the lungs of mice lacking heme oxygenase-2. J Clin Invest 1998; 101:1001.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Welty-Wolf KE, Simonson SG, Huang YC, et al. Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates. II. Morphometric analysis. J Appl Physiol (1985) 1997; 83:559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Otterbein LE, Kolls JK, Mantell LL, et al. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 1999; 103:1047.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 1622 Version 23.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27706466" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Effect of Conservative vs Conventional Oxygen Therapy on Mortality Among Patients in an Intensive Care Unit: The Oxygen-ICU Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29726345" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34924022" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Dangers of hyperoxia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7287745" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22804568" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Oxygen: the poison is in the dose.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9510531" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Oxygen toxicity: a radical explanation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9576762" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9761753" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Oxygen toxicity in mouse lung: pathways to cell death.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11001828" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Signal transduction pathways in hyperoxia-induced lung cell death.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2040698" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8790408" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10194479" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22493012" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Effect of insulin-like growth factor blockade on hyperoxia-induced lung injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22227562" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Increased hyperoxia-induced lung injury in nitric oxide synthase 2 null mice is mediated via angiopoietin 2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31748001" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Risks from Breathing Elevated Oxygen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31748001" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Risks from Breathing Elevated Oxygen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27407317" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : OXYGEN TOXICITY.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30740057" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Pulmonary Oxygen Toxicity in Navy Divers: A Crossover Study Using Exhaled Breath Analysis After a One-Hour Air or Oxygen Dive at Nine Meters of Sea Water.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6205617" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Protective effect of hypoxia on bleomycin lung toxicity in the rat.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1704473" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Oxygen-exacerbated bleomycin pulmonary toxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2409069" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Modification of pulmonary oxygen toxicity by bleomycin treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2410201" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Reactivation of bleomycin lung toxicity following oxygen administration. A second response to corticosteroids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33058991" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Conservative or liberal oxygen therapy in adults after cardiac arrest: An individual-level patient data meta-analysis of randomised controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4921728" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Oxygen toxicity in man. A prospective study in patients after open-heart surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4921729" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Oxygen toxicity in man. A prospective study in patients with irreversible brain damage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3548507" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Prediction of pulmonary function abnormalities after adult respiratory distress syndrome (ARDS).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4601004" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Continuous distributions of ventilation-perfusion ratios in normal subjects breathing air and 100 per cent O2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8087571" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Oxygen toxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10813206" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Hyperoxia and lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10619793" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Pulmonary gas exchange response to oxygen breathing in acute lung injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : The effect of inhalation of high concentrations of oxygen for 24 hours on normal men at sea level and at a simulated altitude of 18,000
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1235760" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Pulmonary effects of oxygen breathing. A 6-hour study in normal men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15563698" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4550633" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : The effect of oxygen toxicity on the inactivation of bacteria by the lung.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6311064" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Decreased bactericidal function and impaired respiratory burst in lung macrophages after sustained in vitro hyperoxia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1248269" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Effect of oxygen in graded concentrations upon tracheal mucous velocity. A study in anesthetized dogs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7713799" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Role of reactive O2 in phagocyte-induced hypermetabolism and pulmonary injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1310457" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Hyperoxic exposure in humans. Effects of 50 percent oxygen on alveolar macrophage leukotriene B4 synthesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2096681" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Effects of normobaric hyperoxia on hemodynamics and O2 utilization in conscious dogs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5016013" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Coronary hemodynamics and myocardial oxygen metabolism during oxygen breathing in patients with and without coronary artery disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/805488" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Light and electron microscopic examinations of experimentally produced heart muscle necroses following normobaric hyperoxia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2793757" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Decreased O2 consumption and cardiac output during normobaric hyperoxia in conscious dogs.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29477145" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Hemodynamic effects of acute hyperoxia: systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32089047" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Effect of Hyperoxia on Myocardial Oxygenation and Function in Patients With Stable Multivessel Coronary Artery Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31636148" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Taking the Air Out of Oxygen Supplementation in Individuals With Diabetes and Acute Coronary Syndromes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27099087" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Central Nervous System Oxygen Toxicity and Hyperbaric Oxygen Seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22362172" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Brother, have you got a light? Assessing the need for intubation in patients sustaining burn injury secondary to home oxygen therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21959207" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Review of burn injuries secondary to home oxygen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25837866" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Burn injury associated with home oxygen use in patients with chronic obstructive pulmonary disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26812246" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Smoking-Related Home Oxygen Burn Injuries: Continued Cause for Alarm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24970359" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Facial hair: a newly identified, modifiable risk factor in home oxygen therapy-related burns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25848719" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : E-cigarette use in patients receiving home oxygen therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5568148" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Continuous oxygen therapy in chronic airway obstruction. Observations on possible oxygen toxicity and survival.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23880677" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Oxidative stress in COPD.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12114185" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Antioxidant responses to oxidant-mediated lung diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2669581" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Pulmonary strategies of antioxidant defense.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12471091" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Vitamin E as an antioxidant of the lung: mechanisms of vitamin E delivery to alveolar type II cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8005847" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Beta-carotene and CNS oxygen toxicity in rats.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8482686" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Polyethylene glycol-conjugated superoxide dismutase protects rats against oxygen toxicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6690485" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Protection against oxygen toxicity by intravenous injection of liposome-entrapped catalase and superoxide dismutase.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9486970" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Oxygen toxicity and iron accumulation in the lungs of mice lacking heme oxygenase-2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9262453" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Aerosolized manganese SOD decreases hyperoxic pulmonary injury in primates. II. Morphometric analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10194478" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
